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Abstract
Background: Preeclampsia continues to affect 5% to 8% of all pregnancies throughout
the world. It is a pregnancy-specific multisystem disorder and a leading cause of
maternal and perinatal morbidity and mortality. The exact pathogenesis of preeclampsia
remains poorly defined. Features of severe preeclampsia include severe proteinuria,
hypertension, symptoms of central nervous system dysfunction, hepatocellular injury
thrombocytopenia, oliguria, pulmonary edema, cerebrovascular accident, and IUGR.
Women with severe preeclampsia must be hospitalized to try to stabilize the disease.
Aim of work: To evaluate maternal, fetal and neonatal outcomes of severe preeclampsia
in Mansoura university Hospitals. Methods: This was a prospective study for one year,
from September 2019 till September 2020, included all gravid women with severe
preeclampsia who were managed at Mansoura University hospitals, Department of
Obstetrics and Gynecology. Results: This study included 204 patients. Regarding
maternal outcomes, the percentages of Placental abruption, Acute renal failure, ICU
admission, DIC, HELLP and PPH were 7.8%, 4.9%, 15.7%, 0.5%, 8.3% and 3.4%,
respectively. Considering fetal outcomes, IUGR developed in 13% of cases, and 13% of
cases ended with IUFD. With regard to neonatal outcomes, the percentages of preterm
delivery, NICU admission low APGAR score were 69%, 62% and 47%, respectively.
Gestational age was the only significant factor to affect incidence of IUFD, NICU
admission and low APGAR score (P<0.001). Conclusion: Pre-eclampsia tends to
threaten maternal health and fetal viability adding to maternal and neonatal mortality and
morbidity. In addition, gestational age was the only significant factor to affect incidence
of IUFD, NICU admission and low APGAR score.

Corresponding author: Rana Mohammed Mostafa El-Adl., MSc student , Department of Obstetrics &amp; Gynaecology E-mail.
ranamostafaeladl@gmail.com. Tel. 0502252105
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INTRODUCTION
Worldwide, preeclampsia is considered to be

complications,

one of the major causes of maternal and

intravascular coagulopathy (DIC), ante-partum

perinatal morbidity and mortality. About 14% of

hemorrhage, liver failure, acute renal failure,

maternal mortality is attributed to preeclampsia-

pulmonary

eclampsia [1]. According to American College

(hemolysis, elevated liver enzymes and low

of Obstetricians and Gynecologists (ACOG) ,

platelet count), eclampsia, retinal detachment, in

preeclampsia

new-onset

addition to maternal mortality. Furthermore,

hypertension with a systolic blood pressure

preeclampsia has many fetal and neonatal

(SBP) of ≥140 mmHg or a diastolic blood

complications,

pressure (DBP) of ≥90 mmHg on 2 occasions, at

intrauterine growth restriction (IUGR) and still

least 4 hours apart, after 20 weeks gestation,

births [3].

with or without proteinuria (≥300 mg per 24-

This study was done to determine maternal, fetal

hour urine collection, protein/creatinine ratio

and neonatal outcomes of severe preeclampsia in

≥0.3, or dipstick reading of 1+) [2].

Mansoura university Hospitals.

In

the

is

absence

defined

of

as;

proteinuria,

such

as;

edema,

such

disseminated

HELLP

as;

preterm

syndrome

delivery,

severe

preeclampsia is diagnosed in the presence of any

Patients and methods:

of the following features: a) severe hypertension

This study was a prospective cohort that took

(a SBP of ≥160 mmHg or a DBP of ≥110 mmHg

one year. It included gravid women with severe

on 2 occasions, at least 4 hours apart), b)

preeclampsia managed at Mansoura University

thrombocytopenia (platelet count of less than

hospitals,

100,000/µL), c) liver dysfunction (raised blood

Gynecology during the period from September

levels of liver transaminases to twice the upper

2019 till September 2020.

normal levels), d) new onset renal insufficiency

Exclusion criteria included uncertain gestational

(raised serum creatinine level than 1.1 mg/dL or

age, fetal abnormalities, pre-existing renal

a doubling of serum creatinine in the absence of

disease, diabetes, asthma requiring steroidal

other renal disease), e) pulmonary edema, or f)

treatment and chronic hepatitis.

new-onset neurological or visual disorders [2].

We collected data about: maternal age, BMI,

Preeclampsia is a disorder with multisystem

parity, gestational age at delivery, mode of

affection, where one or more factors are released

delivery, major maternal complications as: DIC,

throughout the maternal circulation resulting in

HELLP syndrome, placental abruption, intensive

damaging of the vascular endothelial cells. As a

care unit admission (ICU), acute renal failure

result, pregnant women suffering preeclampsia
are at increased risk of developing dangerous
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and
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death (IUFD)

was
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recorded. Regarding neonatal outcomes, the

clinical presentation of severe preeclampsia,

following parameters were noticed mainly; Low

headache was the most common presentation

Apgar score <7, preterm delivery, need for

(57%), followed by vomiting (30%), then

oxygen after delivery and neonatal intensive

epigastric pain (22%), blurring of vision (21%),

care unit (NICU) admission.

oliguria (9%) and generalized edema and ascites

Statistical analysis and data interpretation:

(2%) (Table 3). Mean blood pressure readings

Data were fed to the computer and analyzed

and laboratory results are listed in (Table 4).

using IBM SPSS Corp. Released 2013. IBM

Regarding maternal outcomes, the percentages

SPSS Statistics for Windows, Version 22.0.

of eclampsia, placental abruption, acute renal

Armonk, NY: IBM Corp. Qualitative data were

failure, ICU admission, DIC, HELLP syndrome,

described

percent.

pulmonary edema and post partum hemorrhage

Quantitative data were described using median

(PPH) were 19.6%, 7.8%, 4.9%, 15.7%, 0.5%,

for non-parametric data and mean, standard

8.3% and 3.4% respectively (Table 5). With

deviation for parametric data after testing

regard to fetal outcomes, the percentages of

normality

test.

IUGR and IUFD were 13% each (Table 6). In

Significance of the obtained results was judged

addition, neonatal outcomes revealed that the

at the (0.05) level.

percentages of neonatal need for oxygen after

Ethical consideration

delivery and NICU admission were 67% and

An informed consent was taken from each

62% respectively. 69% of live born babies were

patient included in the study after assuring

delivered preterm. Moreover, APGAR score of

confidentiality. Study protocol was approved by

less than 7 was present in 47% of babies (Table

Institutional Review Board (IRB), Faculty of

7). 87% of cases received magnesium sulphate

medicine, Mansoura University.

(MgSO4). The mean Hospital stay and ICU stay

Results:

duration were 7±4 and 3±1 days respectively

This study included 204 patients with mean age,

(Table 8). Gestational age was the only

BMI and gestational age at delivery of 28±7

significant factor to affect incidence of IUFD,

using

using

number

and

Kolmogrov-Smirnov

2

years, 36±7 kg/m and 34±4 weeks respectively,

NICU admission and low APGAR score

while the median gravidity and parity were 2

(P<0.001) (Tables 9 & 10).

and 1 respectively. Cesarean section (CS) was
demonstrated to be the commonest mode of
delivery (76%) (Tables 1 & 2). Regarding the
Table (1): Demographic characteristics among studied cases (n=204):
Mean±SD
Maternal age/years

28±7

BMI (kg/m2)

Mean±SD

36±7

Gestational age/weeks

Mean±SD

34±4

Published by Mansoura Medical Journal, 2023
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Table (2): Obstetric history of the studied cases (n=204):
median (range)
Gravidity
median (range)
Primigravida
Multigravida
Vaginal
CS

Parity
Gravida
Mode of delivery

2 (1-14)
1 (0-7)
88 (43%)
116 (57%)
50 (24%)
154(76%)

Table (3): Clinical presentation of the studied cases:
N=204
117
62
45
42
19
4

Headache
Vomiting
Epigastric pain
Blurring of vision
Oliguria
Generalized oedema and ascites

%
57%
30%
22%
21%
9%
2%

Table (4): Mean blood pressure and laboratory findings of cases:
Systolic blood pressure
Diastolic blood pressure
Serum creatinine
SGOT
SGPT
HB
Platelet
proteinuria
Albumin

(mmHg)
(mmHg)
(mg/dl)
(IU/L)
(IU/L)
(g/dl)
(×103/μL)
(+)
(g/dl)

Table (5): Maternal outcome distribution among studied cases:
N=204
Eclampsia
40
16
Placental abruption
10
Acute renal failure
32
ICU admission
1
DIC
17
HELLP
0
Pulmonary oedema
7
PPH
0
Maternal mortality
Table (6): Fetal outcome distribution among studied cases:
N=204

Mean±SD
165±14
100±8
0.9±0.5
56±82
47±70
11±1
179±70
3±1
3±0.5

%
19.6%
7.8%
4.9%
15.7%
0.5%
8.3%
0%
3.4%
0%

%

Live birth

177

87%

IUGR

26

13%

IUFD

27

13%
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Table (7): Neonatal outcome distribution among studied cases:
N=177 live birth
122
Preterm
Neonatal need for oxygen after
119
delivery
109
NICU admission
APGAR score
Mean± SD
84
<7
93
≥7
Table (8): MgSO4 and hospital stay duration among studied cases:
N=204
178
MgSO4
Hospital stay/days
Mean±SD

7±4

ICU stay (Duration/days)
Mean±SD

3± 1

%
69%
67%
62%
7±2
47%
53%

%
87%

Table (9): Factors affecting incidence of IUFD and neonatal need for oxygen at delivery among
studied cases:
Risk
neonatal need for
test of
factors
oxygen at delivery
significance
test of
significance
Not
Live birth
IUFD
needed
needed
Maternal
t=1.11
28±7
30±7
29±7
28±7
t=0.254 p=0.800
age/years
p=0.267
Mean±SD
Gravidity
Z=0.392
Z=0.303
2 (1-14)
2 (1-7)
2 (1-9)
2 (1-14)
Median
P=0.695
p=0.762
(range)
Parity
Z=0.275
Z=0.368
1 (0-7)
1 (0-6)
1 (0-6)
1 (0-7)
Median
P=0.784
p=0.713
(range)
Gestational
t=6.50
t=4.74
35±3
30±5
35±4
33±3
age/weeks
p<0.001*
p<0.001*
Mean±SD
χ2=0.135
χ2=1.42
Eclampsia
34 (19%) 6 (22%)
20 (24%)
20(17%)
p=0.713
p=0.233
(%)
Z: Mann Whitney U test, t:Student t test χ2:Chi-Square test *statistically significant if p<0.05

Published by Mansoura Medical Journal, 2023
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Table (10): Factors affecting incidence of NICU admission and low APGAR score among live born
babies:
NICU
APGAR score
Risk
test of
test of
not
factors
significance
significance
admitted
<7
>7
admitted
Maternal
t=0.321
t=1.01
29±7
28±7
28±7
29±7
age/years
p=0.748
p=0.315
Mean±SD
Gravidity
Z=0.059
z=0.029
Median
2 (1-9)
2 (1-14)
2 (1-14) 2 (1-9)
p=0.953
p=0.977
(range)
Parity
Z=.411
z=.541
1 (0-7)
1 (0-6)
1 (0-6)
1 (0-7)
Median
p=0.681
p=0.589
(range)
Gestational
t=6.41
t=13.24
36±4
33±3
32±3
37±2
age/weeks
p=0.001*
p<0.001*
Mean±SD
χ2=1.42
13
21
X2=1.44
Eclampsia
22 (23%)
18 (17%)
p=0.233
(16%)
(23%)
p=0.231
(%)
Z: Mann Whitney U test, t:Student t test χ2:Chi-Square test *statistically significant if p<0.05
Discussion:

However, a lower percentage of 21.3% for

The current study demonstrated that the mean age

primigravidas was reported in the study of

of the studied ladies was 28±7 years, the mean

Pramana et al. (2020) [6].

gestational age was 34±4 weeks and the median of

In

their parity was 1. Similarly, Ngwenya (2017)

demonstrated to be the most common mode of

reported comparable results with mean maternal

delivery (76%). In the same line, Dagdeviren et

age of 27.7±7.4 years, mean gestational age of

al. (2015) [9] reported that a total of 77.1% of

33.4±4.4 weeks gestation and average parity of

preeclamptic women underwent CS. Also, a

121 cases of 1±1 [4].

comparable percentage of 78.5% for CS was

In the present study, the mean BMI was 36±7

reported by Ngwenya (2017) [4]. In contrast, other

kg/m². A comparable mean of BMI (32.22 ± 6.55)

studies showed that vaginal route of delivery was

for patients with severe preeclampsia was reported

more common than CS [10, 3]. But, the high CS

in a similar study, conducted in South Africa, by

rate reported in our study is in line with the most

Ngene and Moodley (2020) [5]. In contrast,

existing literature of increased rate of CS among

Pramana et al. (2020) demonstrated a lower BMI

patients with severe preeclampsia [11].

with an average of 30.89 kg/m², in their study

In terms of clinical presentation, headache was

conducted in Indonesia on cases with severe

demonstrated to be the most common symptom

preeclampsia [6]. This difference may be related to

(57%). In the same context, Singhal et al. (2009)

racial factors.

reported that 44% of patients with severe

The percentage of primigaravidas among studied

preeclampsia had headache as the main presenting

cases was 43%. Comparable percentages were

symptom [12]. Meanwhile, Patnaik et al. (2019)

demonstrated in similar studies [3, 5, 7, 8].

showed that among 120 cases with severe

https://mmj.mans.edu.eg/home/vol50/iss4/1
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preeclampsia,

pedal

edema

was

the

161

main

wide variation of incidence of acute renal failure

complaint (80.8%), followed by headache (40.8%)

among preeclamptic patients has been reported in

[10].

literature, from 1.7% up to 16.76% [1, 3, 4, 13,

With regard to maternal complications in our

14]. These variations in percentages of renal

study, 19.6% of cases had eclampsia. This was in

dysfunction can be attributed to co-morbidities

accordance with the study conducted by Demir et

associated with preeclampsia.

al. (2006) who demonstrated that among 144 cases

Concerning PPH, our study revealed an incidence

with severe preeclampsia, 18% had eclampsia and

of 3.4%. This was in good agreement with the

4.1% had eclampsia plus HELLP syndrome [8]. A

study of Ndoni et al. (2016) that reported an

comparable rate of 21.5% for eclampsia was

incidence of 3.9% for severe PPH among cases

reported in the study of Ngwenya (2017) [4].

with severe preeclampsia [15]. Similarly, a more

Regarding placental abruption, our study reported

or less approaching incidence of 5.8% was

an incidence of 7.8%. This was in coordination

reported by Patnaik et al. (2019) [10].

with the study of Priyanka and Sinha (2020)

Noteworthy, despite the serious nature of severe

which demonstrated that 7.85% of patients with

preeclampsia, no maternal mortality was reported

severe preeclampsia had placental abruption [1].

in the present study. Similarly, no maternal

On the other hand, a lower incidence of 2.5% for

mortalities were observed in similar studies, in

placental abruption was reported in the study of

rich-resourced countries, such as Kuwait and

Ngwenya (2017) [4].

United Kingdom [16, 17]. In contrast, maternal
the

mortalities among cases with severe preeclampsia

percentages of cases with HELLP, DIC and

were reported in other studies, with an incidence of

Pulmonary edema were 8.3%, 0.5% and 0%,

about 1.66% up to 7.14% [1, 4, 8, 10].

respectively.

reported

Regarding ICU admission, the present study

comparable percentages of 9.1%, 0.8% and 0.8%

displayed that 15.7% of cases were admitted to

for the incidences of HELLP, DIC and Pulmonary

ICU. In contrast, Patnaik et al., (2019) reported

edema, respectively [4].

that 4.16% of cases with severe preeclampsia were

In contrast, higher incidences of DIC (13.57%) and

admitted to ICU [10]. This difference can be

Pulmonary edema (2.85%) were reported by

explained by the more incidences of acute renal

Priyanka and Sinha (2020) [1]. This illustrates

failure (4.9% VS 0.83%) and HELLP (8.3% VS

the proper antenatal care which the cases, included

0.83%) in the present study.

in our study, received, leading to more decrease in

Concerning fetal outcomes, the current study

incidence of serious complications, such as DIC

showed that the incidence of IUFD was 13%. An

and pulmonary edema as compared to other similar

approaching incidence was reported in similar

studies.

studies [3, 8].

Concerning renal insult associated with severe

Concerning IUGR, our study revealed an incidence

preeclampsia, our study reported a 4.9% incidence

of 13%. In the same context, a higher incidence of

of acute renal failure among participants. In fact, a

20% was reported by Patnaik et al. (2019) [10].

The

current

study

demonstrated

Ngwenya

(2017)

Published by Mansoura Medical Journal, 2023
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This may be attributed to other co-morbidities

More or less similar incidences of 68.57% and

associated with severe preeclampsia.

70% were reported by Priyanka and Sinha (2020)

The current study demonstrated the incidence of

and Patnaik et al. (2019), respectively [1, 10].

NICU admission was 62% (109/177), and that 47

Lastly, being a single center study and collecting

% of live born babies had APGAR score of less

data over a period of one year are the major

than 7. In the same context, Priyanka and Sinha

limitations of the present study. Therefore, further

(2020) reported a percentage of 78.30% for NICU

multicenter studies should be conducted over

admission, whereas, Ngwenya (2017) reported a

distinctive years in order to highlight maternal,

percentage of 54.5% [1, 4].

fetal

On the other hand, Patnaik et al., (2019) [10]

preeclampsia over a larger scale.

and

neonatal

outcomes

of

severe

reported that 26.6% of neonates were admitted to
NICU and 23.3% of neonates had APGAR score

Conclusion:

of less than 7. These differences in percentages

Pre-eclampsia tends to threaten maternal

may be related to different degrees of respiratory

health and fetal viability adding to maternal and

distress that neonates had developed, as well as

neonatal mortality and morbidity. In addition,

gestational age at time of delivery.

gestational age was the only significant factor to

Regarding preterm delivery, the current study

affect incidence of IUFD, NICU admission and

showed that 69% of live born babies were preterm;

low APGAR score.

born before 37 completed weeks of gestation.
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